These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7862846)

  • 1. A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.
    Dawson GR; Bayley P; Channell S; Iversen SD
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):361-8. PubMed ID: 7862846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
    Dawson GR; Iversen SD
    Behav Brain Res; 1993 Nov; 57(2):143-53. PubMed ID: 8117420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
    Ohno M; Yamamoto T; Watanabe S
    Brain Res; 1994 Jul; 650(2):260-6. PubMed ID: 7953691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates.
    Rupniak NM; Tye SJ; Iversen SD
    J Neurol Sci; 1992 Jul; 110(1-2):222-7. PubMed ID: 1506863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel cholinergic M1 agonist, AF102B, on ambulation and water drinking behavior in rats.
    Togashi H; Matsumoto M; Yoshioka M; Saito Y; Saito H
    Hokkaido Igaku Zasshi; 1991 Jan; 66(1):59-66. PubMed ID: 2004736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents.
    Dawson GR; Bentley G; Draper F; Rycroft W; Iversen SD; Pagella PG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):865-71. PubMed ID: 1763105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
    Nakahara N; Iga Y; Mizobe F; Kawanishi G
    Jpn J Pharmacol; 1988 Dec; 48(4):502-6. PubMed ID: 3244205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of rhythmical slow activity, long-term potentiation and memory by muscarinic receptor agonists.
    Iga Y; Arisawa H; Ise M; Yasuda H; Takeshita Y
    Eur J Pharmacol; 1996 Jul; 308(1):13-9. PubMed ID: 8836627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices.
    Segal M; Fisher A
    Eur J Pharmacol; 1992 Sep; 220(1):103-6. PubMed ID: 1425975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B.
    Brandeis R; Dachir S; Sapir M; Levy A; Fisher A
    Pharmacol Biochem Behav; 1990 May; 36(1):89-95. PubMed ID: 2349275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathoexcitatory action of a novel muscarinic receptor agonist, AF102B, and its blockade by pirenzepine.
    Yoshioka M; Togashi H; Matsumoto M; Morii K; Saito H
    Pharmacol Toxicol; 1990 Jul; 67(1):84-7. PubMed ID: 2395822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis.
    Ogane N; Takada Y; Iga Y; Kawanishi G; Mizobe F
    Neurosci Lett; 1990 Jun; 114(1):95-100. PubMed ID: 2381577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in medicinal chemistry of novel selective muscarinic agonists.
    Fisher A; Karton Y; Heldman E; Gurwitz D; Haring R; Meshulam H; Brandeis R; Pittel Z; Segall Y; Marciano D
    Drug Des Discov; 1993; 9(3-4):221-35. PubMed ID: 8400004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of AF102B and tacrine on delayed match-to-sample in monkeys.
    O'Neill J; Fitten LJ; Siembieda D; Halgren E; Kim E; Fisher A; Perryman K
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):665-78. PubMed ID: 9682279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.
    Fisher A; Heldman E; Gurwitz D; Haring R; Karton Y; Meshulam H; Pittel Z; Marciano D; Brandeis R; Sadot E; Barg Y; Pinkas-Kramarski R; Vogel Z; Ginzburg I; Treves TA; Verchovsky R; Klimowsky S; Korczyn AD
    Ann N Y Acad Sci; 1996 Jan; 777():189-96. PubMed ID: 8624083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
    Ono S; Saito Y; Ohgane N; Kawanishi G; Mizobe F
    Eur J Pharmacol; 1988 Oct; 155(1-2):77-84. PubMed ID: 3243333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.
    Fisher A; Brandeis R; Pittel Z; Karton I; Sapir M; Dachir S; Levy A; Heldman E
    Neurosci Lett; 1989 Jul; 102(2-3):325-31. PubMed ID: 2812509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task.
    Pache DM; Sewell RD; Spencer PS
    J Pharmacol Toxicol Methods; 1999 Aug; 41(4):135-41. PubMed ID: 10691017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.